Compared with a control group who had prescriptions for other inhaled steroids (including the authorized generic of ...

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a ...

The stock market saw 75 stocks at 52-week highs and 25 at lows on Thursday, with Nifty 50 and Sensex declining due to ...

Home First Finance Company India Ltd recorded volume of 4.22 lakh shares by 10:47 IST on BSE, a 25.89 times surge over two-week average daily volume of 16300 shares ...

Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, RNA editing startup Airna tapped a former Sarepta executive to oversee its pipeline.

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE:GSK) Blenrep.

The London-based pharmaceutical company said Blenrep, or belantamab mafodotin, was approved for the treatment of adult patients with multiple myeloma in combination with bortezomib plus dexamethasone, ...

Arexvy, already approved in over 60 countries, was supported by trial data showing safety and immune response in the 50–59 age group. GSK said more than 13 million adults in the US fall into this ...

(Reuters) -British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and ...

After RBI Governor Sanjay Malhotra's announcement, shares of NBFCs like Muthoot Finance and Mannapuram took a sharp dive, nearly 10% and 2.78% respectively. The RBI is set to release a draft set of ...